Cefuroxime Sodium
FDA-approved product (injectable, injection), marketed as Cefuroxime And Dextrose In Duplex Container, Cefuroxime Sodium, Cefuroxime Sodium In Plastic Container and 4 more.
- Registered studies
- 50+
- Lab records
- 17
- Pathogens at ≥40%
- 3 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Bacterial disease
- Eye infection
- Infection
- Pneumonia
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Second-generation cephalosporins; Antibiotics
- Anti-infective classification
- Classified as an existing antimicrobial.WHO ATC J01DC02; WHO ATC S01AA27
Repurposing investigation
Cefuroxime Sodium is already an antimicrobial, so it is not counted among the repurposing candidates. Its AI-predicted activity is shown below for reference.
AI-predicted activity
AI prediction · nothing measured- MRSA94.2% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- E. coli77.2% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- K. pneumoniae20.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- M. tuberculosis46.5% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
- MRSA: measured active in 6 of 6 lab records
- E. coli: measured active in 2 of 2 lab records
- K. pneumoniae: measured active in 1 of 9 lab records
Show the 17 laboratory records, with sources
Loading records…
“Active” means the measured value reached this project’s laboratory cutoff (10 µM or stronger). A laboratory result does not show an effect in patients.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Cefuroxime Sodium with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Etrasimod ArginineExisting use: Ulcerative colitis64.1% AI-predicted activityagainst MRSANo documented evidence found
- MethotrexateExisting use: Acute lymphoblastic leukemia, Adenoma, Arthritis and 21 more64.1% AI-predicted activityagainst MRSA50+ registered studies
- KetoconazoleExisting use: Adrenal gland disease, Blastomycosis, Cushing syndrome and 3 more63.6% AI-predicted activityagainst MRSA50+ registered studies
- LevoketoconazoleExisting use: Adrenal gland disease, Adrenal gland hyperfunction, Cushing syndrome63.6% AI-predicted activityagainst MRSA6 registered studies
- Nafarelin AcetateExisting use: Endometriosis63.6% AI-predicted activityagainst MRSA12 registered studies
- Pafolacianine SodiumExisting use: Other diagnostic agents63.6% AI-predicted activityagainst MRSA1 registered study
- Vinorelbine TartrateExisting use: Cancer, Neoplasm63.6% AI-predicted activityagainst MRSA50+ registered studies
- Ibrexafungerp CitrateExisting use: Vulvovaginal candidiasis63.5% AI-predicted activityagainst MRSANo documented evidence found
- Gonadorelin AcetateExisting use: Gonadotropin-releasing hormones, Tests for fertility disturbances63.4% AI-predicted activityagainst MRSA50+ registered studies
- Icatibant AcetateExisting use: Angioedema, Hereditary angioedema63.4% AI-predicted activityagainst MRSA33 registered studies
- LonafarnibExisting use: Hutchinson-Gilford progeria syndrome, Laminopathies, Progeria63.3% AI-predicted activityagainst MRSA39 registered studies
- LypressinExisting use: Vasopressin and analogues63.2% AI-predicted activityagainst MRSA50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Antibiotic Prophylaxis for Transrectal Prostate Biopsy
NCT01659866 · start 2012-08
Registered record
- Registry ID
- NCT01659866
- Conditions
- Infection
- Interventions
- Ciprofloxacin; trimethoprim-sulfamethoxazole; cefuroxime; ceftriaxone; gentamicin; amikacin; aztreonam; imipenem; ceftriaxone; gentamicin; amikacin; aztreonam; imipenem
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2012-08
- Completion
- 2016-08
- Enrolment
- 563
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInfectionInterventionCiprofloxacin; trimethoprim-sulfamethoxazole; cefuroxime; ceftriaxone +9 morePhasePhase 4Registry statusCompletedPharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care Units
NCT01581047 · start 2012-03-15
Registered record
- Registry ID
- NCT01581047
- Conditions
- Infection
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2012-03-15
- Completion
- 2014-05-07
- Enrolment
- 37
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInfectionInterventionNot recordedPhaseNot recordedRegistry statusCompletedExamination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections
NCT01507974 · start 2012-01-16
Registered record
- Registry ID
- NCT01507974
- Conditions
- Pregnancy Complications
- Interventions
- Preventive antibiotic treatment- NITROFURANTOIN; Preventive antibiotic treatment- CEPHALEXIN; PREVENTIVE TREATMENT- AMOXICILLIN; PREVENTIVE TREATMENT- AMOXICILLIN AND CLAVULANATE POTASSIUM; PREVENTIVE TREATMENT- CEFUROXIME; PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2012-01-16
- Completion
- 2015-01-01
- Enrolment
- 220
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPregnancy ComplicationsInterventionPreventive antibiotic treatment- NITROFURANTOIN; Preventive antibiotic treatment- CEPHALEXIN; PREVENTIVE TREATMENT- AMOXICILLIN; PREVENTIVE TREATMENT- AMOXICILLIN AND CLAVULANATE POTASSIUM +2 morePhaseNot applicableRegistry statusCompletedLaparoscopic Management of Periappendicular Abscess
NCT01283815 · start 2011-01
Registered record
- Registry ID
- NCT01283815
- Conditions
- Appendicitis; Abdominal Abscess
- Interventions
- Laparoscopic appendectomy; Conservative management with percutaneous drainage
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2011-01
- Completion
- 2014-08
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAppendicitis; Abdominal AbscessInterventionLaparoscopic appendectomy; Conservative management with percutaneous drainagePhasePhase 2Registry statusCompletedTailored Antibiotics Prophylaxis for Percutaneous Endoscopic Gastrostomy
NCT01237730 · start 2010-07
Registered record
- Registry ID
- NCT01237730
- Conditions
- The Patients Who Receive Percutaneous Endoscopic Gastrostomy; Peristomal Wound Infection After the Operation of PEG; Prophylactic Antibiotics Before PEG
- Interventions
- cefuroxime; Tailored antibiotic
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2010-07
- Completion
- 2011-08
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionThe Patients Who Receive Percutaneous Endoscopic Gastrostomy; Peristomal Wound Infection After the Operation of PEG; Prophylactic Antibiotics Before PEGInterventioncefuroxime; Tailored antibioticPhaseNot applicableRegistry statusUnknownMonotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia
NCT00818610 · start 2009-01
Registered record
- Registry ID
- NCT00818610
- Conditions
- Community-acquired Pneumonia
- Interventions
- Beta lactam (amoxicillin / clav. acid OR cefuroxime); Beta-lactam (amoxicillin / clav. acid OR cefuroxime) AND macrolide (clarithromycin)
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2009-01
- Completion
- 2013-04
- Enrolment
- 601
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCommunity-acquired PneumoniaInterventionBeta lactam (amoxicillin / clav. acid OR cefuroxime); Beta-lactam (amoxicillin / clav. acid OR cefuroxime) AND macrolide (clarithromycin)PhasePhase 4Registry statusCompletedThe Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery
NCT00730938 · start 2008-02
Registered record
- Registry ID
- NCT00730938
- Conditions
- Cataract; Endophthalmitis
- Interventions
- cefuroxime; Saline placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2008-02
- Completion
- 2008-08
- Enrolment
- 45
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCataract; EndophthalmitisInterventioncefuroxime; Saline placeboPhaseNot applicableRegistry statusCompletedOrally Administered Trimethoprim-sulfamethoxazole and Metronidazole as Prophylaxis of Infection Following Elective Colorectal Surgery
NCT00613769 · start 2007-09
Registered record
- Registry ID
- NCT00613769
- Conditions
- Infection Prophylaxis in Colo Rectal Surgery
- Interventions
- trimethoprim-sulfamethoxazole + metronidazole; cefuroxime and metronidazole
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2007-09
- Completion
- 2012-05
- Enrolment
- 1,073
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInfection Prophylaxis in Colo Rectal SurgeryInterventiontrimethoprim-sulfamethoxazole + metronidazole; cefuroxime and metronidazolePhasePhase 4Registry statusCompletedAntibiotics in Free Flaps Reconstructions
NCT02436083 · start 2007-07
Registered record
- Registry ID
- NCT02436083
- Conditions
- Postoperative Infection
- Interventions
- antibiotic (use of penicilline, unacid, cefuroxime)
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2007-07
- Completion
- 2014-12
- Enrolment
- 350
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPostoperative InfectionInterventionantibiotic (use of penicilline, unacid, cefuroxime)PhasePhase 4Registry statusCompletedComparison of Doxycycline and Cefuroxime Axetil in Erythema Migrans
NCT03584919 · start 2006-06-01
Registered record
- Registry ID
- NCT03584919
- Conditions
- Erythema Chronicum Migrans
- Interventions
- doxycycline; Cefuroxime Axetil 500Mg Tab; control subjects
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2006-06-01
- Completion
- 2007-09-30
- Enrolment
- 509
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionErythema Chronicum MigransInterventiondoxycycline; Cefuroxime Axetil 500Mg Tab; control subjectsPhaseNot applicableRegistry statusCompletedInflammatory Responses in Solitary and Multiple Erythema Migrans
NCT03980015 · start 2006-06-01
Registered record
- Registry ID
- NCT03980015
- Conditions
- Erythema Migrans
- Interventions
- antibiotic treatment
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2006-06-01
- Completion
- 2019-05-31
- Enrolment
- 134
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionErythema MigransInterventionantibiotic treatmentPhaseNot recordedRegistry statusCompletedComparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome
NCT01518192 · start 2006-06
Registered record
- Registry ID
- NCT01518192
- Conditions
- Erythema Migrans; Post-Lyme Disease Symptoms
- Interventions
- doxycycline; cefuroxime axetil
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2006-06
- Completion
- 2009-01
- Enrolment
- 544
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionErythema Migrans; Post-Lyme Disease SymptomsInterventiondoxycycline; cefuroxime axetilPhasePhase 4Registry statusCompletedDo Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?
NCT00492973 · start 2006-03
Registered record
- Registry ID
- NCT00492973
- Conditions
- Osteoarthritis; Post-traumatic; Arthrosis
- Interventions
- methylprednisolone acetate; active comparator
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2006-03
- Completion
- 2008-02
- Enrolment
- 101
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOsteoarthritis; Post-traumatic; ArthrosisInterventionmethylprednisolone acetate; active comparatorPhaseNot applicableRegistry statusCompletedAmpicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section
NCT01138852 · start 2004-07
Registered record
- Registry ID
- NCT01138852
- Conditions
- Surgical Site Infections
- Interventions
- Ampicillin-sulbactam; Cefuroxime
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2004-07
- Completion
- 2008-12
- Enrolment
- 176
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSurgical Site InfectionsInterventionAmpicillin-sulbactam; CefuroximePhasePhase 4Registry statusCompletedPERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis
NCT00132938 · start 2004-01
Registered record
- Registry ID
- NCT00132938
- Conditions
- Chronic Bronchitis
- Interventions
- telithromycin
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2004-01
- Completion
- 2006-05
- Enrolment
- 5,660
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic BronchitisInterventiontelithromycinPhasePhase 4Registry statusCompleted